-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Reiterates Buy on Zymeworks, Raises Price Target to $44

Benzinga·08/10/2026 17:19:58
Listen to the news
B. Riley Securities analyst Mayank Mamtani reiterates Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $40 to $44.